A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination with OGX-427 in Patients with Relapsed or Refractory Metastatic Urothelial Carcinoma after Receiving a Platinum-Containing Regimen Hoosier Oncology Group GU12-160; The Borea

SUMMARY

N/A

COH Protocol Number : 13145

ClinicalTrials.gov Number : NCT01780545

Principal Investigator : Pal, Sumanta M.D.

Sponsor : Hoosier Oncology Group

BRIEF ELIGIBILITY CRITERIA :

Eligible Ages : >=18

Gender : Either

Treatment Intent : Non-Adjuvant treatment

Prior Chemotherapy :

Brain Metastases :

Measurable Disease :